Publications

Year of Publication Title Faculty Association
2017 Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. John M. Streicher, PhD
2017 Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy. Nam Lee, Ph.D.
2017 Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain. John M. Streicher, PhD
2017 Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics. Frank Porreca, PhD
2017 Remote Ischemic Conditioning Preserves Cognition and Motor Coordination in a Mouse Model of Traumatic Brain Injury. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2017 Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke.
2017 Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers. John M. Streicher, PhD
2017 Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice. John M. Streicher, PhD
2017 Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. Roberta Diaz Brinton, Ph.D
2017 Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2017 Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System. Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS
2017 Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. John M. Streicher, PhD
2017 Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2017 Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy. Nam Lee, Ph.D.
2017 Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2017 Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides. Todd Vanderah, PhD
2017 Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease. Roberta Diaz Brinton, Ph.D
2017 Long-lasting antinociceptive effects of green light in acute and chronic pain in rats. Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, T. Philip Malan, PhD, MD, Frank Porreca, PhD, Todd Vanderah, PhD
2017 Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder. Jeffrey J. Lochhead, PhD
2017 Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists. Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2017 Editorial: The Metabolic-Inflammatory Axis in Brain Aging and Neurodegeneration. Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D.
2017 Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke. Patrick T Ronaldson, PhD, FAAPS
2016 Neuroendocrinology: Oestrogen therapy affects brain structure but not function. Roberta Diaz Brinton, Ph.D
2016 Various modifications of the amphipathic dynorphin A pharmacophore for rat brain bradykinin receptors. Frank Porreca, PhD
2016 Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, John M. Streicher, PhD, Todd Vanderah, PhD

Pages